Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper

Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper

Introduction People of Ashkenazi Jewish (AJ) ancestry are more likely than unselected populations to have a BRCA1/2 pathogenic variant, which cause a significantly increased risk of breast, ovarian and prostate cancer. Three specific BRCA1/2 pathogenic variants, referred to as BRCA-Jewish founder mu...

Full description

Bibliographic Details
Main Authors: Martin B Delatycki, Chris Jacobs, Bettina Meiser, Ian G Campbell, Lesley Andrews, Paul A James, Yi-An Ko, Alison Trainer, AGNES BANKIER, Kristine Barlow-Stewart, Jane Tiller, Nicole E Cousens, Simone Rowley, Sakshi Mahale, Rajneesh Kaur, Leslie Burnett, Suzanne Neil
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/6/e041186.full

Internet

https://bmjopen.bmj.com/content/11/6/e041186.full

Similar Items